Guangdong province 2017 medical and health industry investment: 152 investment cases 10.5 billion investment value release date: 2018-01-06

As the south gate of our country, guangdong province has abundant private capital and constantly promotes the rapid development of the regional medical and health industry. According to the data, there were 152 cases of investment in the medical and health industry in guangdong province in 2017, and the number of disclosure of the investment amount was 80, and the disclosure amount was about 10.491 billion yuan.

Yang chao wen |

South of guangdong province in China, rely on the unique geographical advantages, not only on the economy play an important contribution to the national economic growth and supporting role, in the biological medicine industry also ranks high in the country. "Twelfth five-year" period, biological medicine industry of guangdong province to maintain the rapid growth of 12%, biological technical service and so on main biological industry competitiveness among the top, the pearl river delta region has become one of the most important biological medicine industrial clusters in China.

In addition to this, guangdong in storage and molecular diagnostic equipment and reagents, stem cell therapy, modern extraction and separation of Chinese medicine, Marine biological genetic screening niche also broke through a number of key technologies, some of the technology is in the world is in the lead. Data show that the production value of the bio-pharmaceutical industry in guangdong province exceeded 300 billion yuan in 2016. Among them, the pharmaceutical industry produces 150 billion yuan of output value, the medical device industry produces 35 billion RMB, and the genetic testing industry has exploded, with an average annual growth rate of over 50%.

Shenzhen is the window and test field for China's reform and opening up, and the development of biological and life health industries is also at the forefront of the country. Life in recent years, shenzhen health industry by an average 15% growth in rapid development, 2015, biological and health industry reached 200 billion yuan, prominent superiority in the field of biological medicine and gene sequencing. In addition, shenzhen is also the policy guidance, talent introduction and cultivation, innovation ability and promote vigorously support the development of biological medicine industry, the construction of national biomedical industry base, national high and new technology industry innovation center in shenzhen, shenzhen international biological valley, a number of important carrier.

Flint create public data shows, within the scope of medical health industry in guangdong province in 2017 cases, 152 cases of total investment, the case of disclosure of investment amount to 80, disclosure of the amount of about 10.491 billion yuan, the average single cases investment amount more than 131 million yuan. There are 24 cases involving more than 100 million yuan and more than 9449 million yuan in total investment. Among them, two companies have invested more than 1 billion RMB, respectively: POCT testing products manufacturer - raylai creature was acquired by runda medical treatment for 1.779 billion yuan; The comprehensive medical service organization, bodejia lian, received a strategic investment of 1 billion RMB yuan.

Case study of guangdong province's investment in 2017 in excess of RMB 1 billion yuan (part)

Statistical analysis found that according to the investment stage, medical health industry in guangdong province in 2017 152 portfolio is focused on the stage, A round, A total of 31 cases of disclosure of investment amount has 13, disclose the total of about 1.065 billion yuan, the average single cases investment amount is about 81.9308 million yuan, of which medical electric business platform, health financing from $50 million, this year guangdong area up the case of A round of investment stage financing amount.

Angel round stage of our portfolio of 27 number, the number after A round of stage, the disclosure of investment amount with 14 cases, disclose the total of about 79.3 million yuan, the average single cases investment amount is about 5.6643 million yuan, including Dan precision medical intelligence platform - anji Kang Er China endowment ability of 15 million RMB financing, become this year guangdong area angel round up the case of investment stage financing amount.

The number of cases and the amount of the investment phase of medical health industry in guangdong province in 2017

In 2017, the health care industry in guangdong province seven companies mergers and acquisitions, involving about 1.547 billion yuan, the highest amount of m&a incident is POCT testing, product manufacturers, biological, medical mergers and acquisitions in 1.179 billion yuan. According to statistics, in 2017 the guangdong region a total of three companies in the field of pharmaceutical circulation by mergers and acquisitions, accounting for merger and acquisition of 42.86% of the total number of cases, in guangdong province respectively, proprietary Chinese medicine and biochemical drugs wholesaler, mergers and acquisitions, baina lates brigitte students to 6 million yuan; Pharmaceutical sales chain - good faith medicine was acquired by Vipshop for 22.8 million yuan; Ollie, a drug and medical device retailer, was acquired by bi shengyuan for 1.5 million yuan. In addition, there is a merger of drugs, medical devices, in vitro diagnosis and medical services.

The case of guangdong medical health industry merger and acquisition in 2017

In 2017, a total of 10 successful ipos in guangdong province's health care industry have raised about 50.31 billion yuan. Among them, the public raising of 989 million yuan ($989 million) is the highest in guangdong province this year. According to statistics, there are four ipos in the pharmaceutical field, accounting for 25% of the total number of ipos, with a total public offering of 1.83 billion yuan. There are two ipos in the field of medical devices, with a total capital raising of 775 million yuan. In the field of medical services, there are two ipos, with a total capital raising of 1.23 billion yuan. In the field of extracorporeal diagnosis, there is a public offering of RMB 414 million. In the field of medical circulation, there are one IPO listed in the field of pharmaceutical circulation, which has raised 989 million yuan. Among them, listed on the Shanghai stock exchange, listed in shenzhen stock exchange, Hong Kong stock exchange listed home, nasdaq listed.

A case study of the IPO of health care industry in guangdong province in 2017

Medical health industry niche investment in guangdong province in 2017, the largest number of niche in our portfolio for medical services, including mobile medical treatment, medical informatization, artificial intelligence, medical big data, and other fields, our portfolio total of 62 cases, accounting for 40.79% of the total number of cases; The second is the field of medical devices, including medical imaging, implantation/interventional devices, medical robots, medical electronic instruments and equipment, etc. The total number of investment cases has reached 31, accounting for 20.39% of the total. In the field of extracorporeal diagnosis, the total number of investment cases reached 19, accounting for 12.50% of the total number of cases. Once again, the field of medicine, including chemical medicine/preparation, biological medicine/products, cell therapy, gene therapy, CRO/CMO service, etc., covers 17 cases, accounting for 11.18% of the total number of cases. In addition, the number of investment cases in pharmaceutical circulation was 15, accounting for 9.87% of the total. The number of investment cases in the pharmaceutical industry was 2, about 1.32 percent of the total.

The distribution of investment cases in the 2017 medical health industry segment of guangdong province (by case number/start)

Medical health industry niche investment in guangdong province in 2017, total investment cases accounted for the highest niche is medical services, accounting for 29.84% of the total, is one of the highest investment case comprehensive medical service institutions - Byrd jia league get fresh air tianyu investment of 1 billion RMB financing strategy. The second is the pharmaceutical sector, which accounts for 22.25% of the total, with the highest investment in the case of the pharmaceutical group, which publicly raised 682 million yuan in IPO. It is again in the field of in vitro diagnosis, accounting for 20.06% of the total amount, and the highest investment amount is the POCT testing product manufacturer, the raylai creature was acquired by runda medical treatment for 1.779 billion yuan. After that, the field of medical circulation and medical devices accounted for 14.36% and 12.69% respectively.

The distribution of investment cases in the 2017 medical and health industry segment of guangdong province (by investment amount/RMB 100 million)

Guangdong medical health industry in the VC/PE event in 2017, top 10 cases total financing amount raised about 2.735 billion yuan, mainly concentrated in the investment stage A and B rounds, the maximum amount of financing case is comprehensive medical service institutions - Byrd jia league get fresh air tianyu investment of 1 billion RMB financing strategy.

Top 10 cases of the financing amount of medical health industry in guangdong province in 2017 (part)